DHB Odin Pharma 10ml Odin Pharmaceuticals

£132.00

Dihydroboldenone (DHB), sometimes called 1-testosterone, is a DHT-family injectable compound distinct from boldenone itself despite the similar name, and does not aromatise.

Add to Wishlist
Add to Wishlist
SKU: EU24700 Category: Brand:

Description

Dihydroboldenone (DHB), sometimes called 1-testosterone, is a DHT-family injectable compound distinct from boldenone itself despite the similar name, and does not aromatise.

Dihydroboldenone in brief

A dht-family injectable, not testosterone-derived. Odin Pharmaceuticals is the named manufacturer for this listing. This item is filed under injectable steroids.

Specifications

Odin Pharmaceuticals Dihydroboldenone — Specifications
Spec Value
Compound Dihydroboldenone (DHB) (Cypionate)
Volume 10 ml
CAS number 4267-80-5
Manufacturer Odin Pharmaceuticals

Cypionate versus other esters

DHB is supplied esterified similarly to other injectables (commonly as a cypionate), with the ester determining release speed rather than the parent hormone.

Legal status

Dihydroboldenone is a Class C controlled substance in the UK under the Misuse of Drugs Act 1971. It is not a licensed human medicine and is treated as prescription-only where used clinically. This page is research and reference material only; the UK Government’s FRANK service sets out the law. No medical or performance claims are made, and dosing belongs with a qualified professional.

Frequently asked questions

Is DHB the same as boldenone? No. DHB is dihydroboldenone, a distinct DHT-family compound, not the same molecule as boldenone.

Does DHB aromatise? No, as a DHT-family compound it does not convert to oestrogen.

What ester is this? Check the specification table for the specific ester and concentration of this listing.

Is DHB legal in the UK? It is treated as a Class C controlled substance under the Misuse of Drugs Act 1971.

Reviews

There are no reviews yet.

Be the first to review “DHB Odin Pharma 10ml Odin Pharmaceuticals”

Your email address will not be published. Required fields are marked *